Clin2
NCT07627815Possibly a fitRecruiting

Safety and Efficacy of PNMR for Long COVID

Long COVID

Part of Infections, Lungs & breathing clinical trials.

This study tests whether PNMR (a supplement product) can safely reduce symptoms of long COVID—the lingering fatigue, brain fog, and other problems that some people experience months after COVID infection. You'll take the study product, follow diet and exercise guidelines, and complete questionnaires and a walking test.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
82 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • At least 19 years old
  • Had confirmed COVID-19 infection more than 4 weeks ago
  • Experiencing long COVID symptoms (lasting at least 3 months after infection, with symptoms for at least 2 months with no other explanation)
  • Have tested negative for COVID-19 at least 4 weeks before starting the study
  • Willing to stop all over-the-counter supplements, vitamins, and certain medications during the study
  • Able to swallow multiple capsules and follow diet and exercise recommendations

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07397910Not yet recruiting
A natural compound for long COVID inflammation

This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.

Murcia
NCT07697261Not yet recruiting
Fatigue treatment study for Long COVID patients

This study tests a program to help reduce fatigue and other symptoms in people with Long COVID. It involves using an internet-connected device to access the program remotely.

NCT06920628Recruiting· Phase 1
Brain scan study for long COVID neurological symptoms

This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.

Bethesda, Maryland
NCT07597902Not yet recruiting· Phase 2
Testing antivirals to help Long COVID symptoms

This study tests whether medicines that fight viruses (similar to those used for herpes or COVID) can reduce Long COVID symptoms like fatigue and brain fog. Researchers believe lingering viruses or viral reactivation may drive Long COVID, and this trial will see if antiviral drugs help.

New York, New York
NCT06721949Recruiting· Phase 2/Phase 3
Taurine for long COVID symptoms

This trial tests if taking taurine, a natural amino acid supplement, can help reduce lingering symptoms of COVID-19 that last for months. If you have had COVID-19 and still have symptoms like fatigue or brain fog for at least 2 months after 3 months from your infection, this study might be for you.

Edmonton, Alberta
NCT06940609Recruiting· Phase 2
Brain scan study for Long COVID brain fog

This trial studies if brain scans can help understand 'brain fog' in Long COVID. It also looks at how a gentle magnetic stimulation might affect symptoms. If you have ongoing thinking problems after COVID, this study may help find new ways to help.

Albuquerque, New Mexico

Hear when a new Long COVID trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.